CHMMF (Chimeric Therapeutics) ROE % Adjusted to Book Value : -268.04% (As of Dec. 2024)

Chimeric Therapeutics ROE % Adjusted to Book Value Chart

Competitive Comparison of Chimeric Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Chimeric Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chimeric Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chimeric Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Chimeric Therapeutics's ROE % Adjusted to Book Value falls into.

Chimeric Therapeutics ROE % Adjusted to Book Value Calculation

Chimeric Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

Chimeric Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chimeric Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Chimeric Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Chimeric Therapeutics Business Description